Literature DB >> 6784302

Somatic variants in mouse myeloma and hybridoma cell lines.

D E Yelton, W D Cook, M D Scharff.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6784302

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  4 in total

1.  Present status and future prospects for the hybridoma technology.

Authors:  M D Scharff; S Roberts
Journal:  In Vitro       Date:  1981-12

Review 2.  Tumor progression in metastasis: an experimental approach using lectin resistant tumor variants.

Authors:  R S Kerbel; J W Dennis; A E Largarde; P Frost
Journal:  Cancer Metastasis Rev       Date:  1982       Impact factor: 9.264

3.  Mutant monoclonal antibodies with alterations in biological functions.

Authors:  D E Yelton; M D Scharff
Journal:  J Exp Med       Date:  1982-10-01       Impact factor: 14.307

4.  Somatically generated mouse myeloma variants synthesizing IgA half-molecules.

Authors:  D J Zack; S L Morrison; W D Cook; W Dackowski; M D Scharff
Journal:  J Exp Med       Date:  1981-11-01       Impact factor: 14.307
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.